← Back to Discover
Propel Bio Management, LLC
Period ended Jun 30, 2026 · Latest filing Aug 13, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $191,085,715
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- PLAINS GP HOLDINGS LP-CL · COMM · 72651A207 · shares: $30,880,177
- ACHIEVE LIFE SCIENCES INC · COMM · 004468500 · shares: $26,342,138
- CORCEPT THERAPEUTICS INC · COMM · 218352102 · shares: $11,868,588
- PHATHOM PHARMACEUTICALS I · COMM · 71722W107 · shares: $11,396,384
- DELCATH SYSTEMS INC · COMM · 24661P807 · shares: $10,971,681
- MILESTONE PHARMACEUTICALS · COMM · 59935V107 · shares: $9,955,651
- COMPASS PATHWAYS PLC · ADRS · 20451W101 · shares: $8,109,167
- KYVERNA THERAPEUTICS INC · COMM · 501976104 · shares: $7,869,294
- ARTIVA BIOTHERAPEUTICS IN · COMM · 04317A107 · shares: $6,755,429
- ABEONA THERAPEUTICS INC · COMM · 00289Y206 · shares: $6,075,373
Reported holdings
29 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| PLAINS GP HOLDINGS LP-CL | COMM | 72651A207 | — | 1,272,360 shares | $30,880,177 |
| ACHIEVE LIFE SCIENCES INC | COMM | 004468500 | — | 4,034,018 shares | $26,342,138 |
| CORCEPT THERAPEUTICS INC | COMM | 218352102 | — | 136,499 shares | $11,868,588 |
| PHATHOM PHARMACEUTICALS I | COMM | 71722W107 | — | 1,050,358 shares | $11,396,384 |
| DELCATH SYSTEMS INC | COMM | 24661P807 | — | 871,460 shares | $10,971,681 |
| MILESTONE PHARMACEUTICALS | COMM | 59935V107 | — | 7,429,590 shares | $9,955,651 |
| COMPASS PATHWAYS PLC | ADRS | 20451W101 | — | 573,086 shares | $8,109,167 |
| KYVERNA THERAPEUTICS INC | COMM | 501976104 | — | 883,198 shares | $7,869,294 |
| ARTIVA BIOTHERAPEUTICS IN | COMM | 04317A107 | — | 696,436 shares | $6,755,429 |
| ABEONA THERAPEUTICS INC | COMM | 00289Y206 | — | 983,070 shares | $6,075,373 |
| AQUESTIVE THERAPEUTICS IN | COMM | 03843E104 | — | 1,442,397 shares | $6,000,372 |
| PALISADE BIO INC | COMM | 696389402 | — | 2,582,388 shares | $5,397,191 |
| IMMUNIC INC | COMM | 4525EP200 | — | 325,022 shares | $4,995,588 |
| INVENTIVA SA - ADR | COMM | 46124U107 | — | 1,281,212 shares | $4,842,981 |
| SAB BIOTHERAPEUTICS INC | COMM | 78397T202 | — | 1,076,578 shares | $4,198,654 |
| ORCHESTRA BIOMED HOLDINGS | COMM | 68572M106 | — | 896,701 shares | $3,869,265 |
| CELLDEX THERAPEUTICS INC | COMM | 15117B202 | — | 103,695 shares | $3,858,491 |
| ZEVRA THERAPEUTICS INC | COMM | 488445206 | — | 253,544 shares | $3,635,821 |
| OCULAR THERAPEUTIX INC | COMM | 67576A100 | — | 357,966 shares | $3,515,226 |
| 4D MOLECULAR THERAPEUTICS IN | COMM | 35104E100 | — | 252,654 shares | $3,360,298 |
| OVID THERAPEUTICS INC | COMM | 690469101 | — | 1,115,538 shares | $3,000,797 |
| EYEPOINT INC | COMM | 30233G209 | — | 191,745 shares | $2,741,954 |
| UPSTREAM BIO INC | COMM | 91678A107 | — | 350,389 shares | $2,424,692 |
| SCYNEXIS INC | COMM | 811292309 | — | 543,478 shares | $2,211,955 |
| SILENCE THERAPEUTICS PLC | ADRS | 82686Q101 | — | 191,733 shares | $2,105,228 |
| LEONABIO INC | COMM | 04746L203 | — | 149,279 shares | $1,371,874 |
| MAZE THERAPEUTICS INC | COMM | 578784100 | — | 43,798 shares | $1,306,932 |
| CORVUS PHARMACEUTICALS INC | COMM | 221015100 | — | 70,380 shares | $1,051,477 |
| SAGIMET BIOSCIENCES INC-A | COMM | 786700104 | — | 125,878 shares | $973,037 |